In the ever-evolving landscape of healthcare, groundbreaking innovations are not merely celebrated for their scientific ...

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...

Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed ...

A review published in Nutrients finds that ketogenic diets (KD) may offer superior benefits for weight loss, blood sugar ...

A new study suggests that medications commonly used for diabetes, including the popular drug Ozempic, may help reduce the ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...

This innovative approach aims to improve blood glucose management and reduce the risk of serious complications.

Diabetes affects more than 1 in 10 adults worldwide and has been accompanied by an increase in vision-threatening diabetic retinal disease.

The Emily Program, a nationally recognized leader in eating disorder specialty care and behavioral health services, today announced an expansion of care that fills a critical gap in eating disorder ...